Introduction {#Sec1}
============

Type 2 diabetes mellitus (DM2) is characterized histopathologically by the presence of fibrillar amyloid deposits in the pancreatic islets of Langerhans (islet amyloid). The main component of these amyloid fibrils is the 37-amino-acid residue human islet amyloid polypeptide (hIAPP), a hormone that is normally co-secreted with insulin by the β-cells of the pancreas (Westermark et al. [@CR31]). Although the normal physiological role of hIAPP is not entirely clear, it has been shown that the peptide plays a role as a hormone in suppression of gastric emptying, food intake, and glucose homeostasis (Akesson et al. [@CR2]; Reda et al. [@CR24]; Rushing et al. [@CR26]).

It is thought that hIAPP amyloid formation is cytotoxic to the islet β-cells (Höppener et al. [@CR15]; Khemtémourian et al. [@CR19]), and that this cytotoxicity involves membrane disruption by growing IAPP fibrils (Engel et al. [@CR13]) or by toxic hIAPP oligomers (Demuro et al. [@CR10]; Engel [@CR11]; Jayasinghe and Langen [@CR17]; Kayed et al. [@CR18]). It is well established that hIAPP is able to interact with membranes and that membranes can promote the aggregation of hIAPP (Knight and Miranker [@CR20]; Janson et al. [@CR16]; Sparr et al. [@CR29]). The initial step of membrane interaction of mature hIAPP is insertion of its N-terminus, most likely as the monomer (Engel et al. [@CR12]). This N-terminus contains an evolutionary conserved disulfide bond between Cys2 and Cys7, presumably formed in the oxidizing environment of the endoplasmic reticulum. This disulfide bond has been shown to be essential for biological activity of hIAPP, i.e. its effect on insulin-stimulated glycogen synthesis (Roberts et al. [@CR25]). Possibly related to this, an important role for the disulfide bridge was demonstrated in heparin binding (Abedini et al. [@CR1]). With regard to its role in amyloid formation, it has been shown that the disulfide prohibits the N-terminal region of hIAPP from adopting a β-sheet-rich structure (characteristic of amyloid fibrils) and that it is involved in amyloid formation in solution, albeit not as part of the core (Koo and Miranker [@CR21]). However, to our knowledge no reports have yet been published on the possible role of the disulfide bond of hIAPP in membrane-interaction.

Because the disulfide bond is located in the N-terminal part of the peptide, and because the N-terminal part is primarily responsible for the interaction of hIAPP with membranes, we examined the effect of this disulfide on insertion of the peptide hIAPP~1--19~ into membranes. In particular, we have examined the aggregational behavior, the membrane insertion, the secondary structure and the effect on lipid acyl chain order and on membrane leakage. For this purpose, we generated two hIAPP~1--19~ peptides (oxidized and protected hIAPP~1--19~, Fig. [1](#Fig1){ref-type="fig"}) and we investigated their interaction with model membranes composed of a mixture of the zwitterionic lipid phosphatidylcholine (POPC) and the anionic lipid phosphatidylserine (POPS) in a 7:3 ratio to mimic the membranes of pancreatic islet cells (Rustenbeck et al. [@CR27]).Fig. 1Amino acid sequences of oxidized and protected hIAPP~1--19~. Both peptides have an amidated C-terminus

Materials and methods {#Sec2}
=====================

Materials {#Sec3}
---------

1-Palmitoyl-2-oleoyl-*sn*-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-*sn*-glycero-3-phospho-[l]{.smallcaps}-serine (POPS), and chain perdeuterated POPC and POPS (POPC-^2^H~31~ and POPS-^2^H~31~) were purchased from Avanti Polar Lipids (Alabaster, AL, USA).

Peptide synthesis and purification {#Sec4}
----------------------------------

The peptides (see Fig. [1](#Fig1){ref-type="fig"} for the amino acid sequence) were synthesized using Fmoc chemistry on a Tentagel S RAM resin to provide an amidated C-terminus. Fmoc--Cys(Me)--OH was used for the synthesis of the protected peptide; Fmoc--Cys(Trt)--OH was used for the synthesis of the linear peptide. Linear hIAPP~1--19~ was dissolved in aqueous DMSO and oxidized with air to the corresponding disulfide bond. All peptides were purified by HPLC using an Alltima C~8~ column (100 Å pore size, 10 μm particle size, 25 × 2.2 cm). The peptides were eluted with a flow rate of 12.5 ml/min. using a linear gradient of buffer B (100% in 100 min) from 100% buffer A (0.1% TFA in CH~3~CN--H~2~O 5:95 *v*/*v*), buffer B (0.1% TFA in CH~3~CN--H~2~O 95:5 *v*/*v*). Purity of the peptides was higher than 95% as determined by analytical HPLC, and the masses of the peptides were confirmed with MALDI-TOF mass spectrometry.

Preparation of peptide samples {#Sec5}
------------------------------

Peptide stock solutions were prepared by dissolving the peptide at a concentration of 1 m[M]{.smallcaps} in hexafluoroisopropanol (HFIP) and incubating for at least 1 h. Next, HFIP was evaporated, followed by vacuum desiccation for 20 min. The resulting peptide film was then dissolved to a final peptide concentration of 1 m[M]{.smallcaps} in either DMSO for the monolayer or in an appropriate buffer containing the vesicles for the CD and the NMR experiments.

Monolayer experiments {#Sec6}
---------------------

Peptide-induced changes in the surface pressure of a monomolecular layer of phospholipids at constant surface area were measured with the Wilhelmy plate method, as reported previously (Engel et al. [@CR12]). Surface pressures were measured at 22(±2)°C. Briefly, a Teflon trough was filled with 6.0 ml 10 m[M]{.smallcaps} Tris--HCl, 100 m[M]{.smallcaps} NaCl buffer (pH 7.4). Lipid monolayers were spread from a 1 m[M]{.smallcaps} stock solution in chloroform, after which 10 μl of a 600 μ[M]{.smallcaps} freshly prepared stock solution of the peptide was injected into the sub-phase. The final peptide concentration was 1 μ[M]{.smallcaps}.

Preparation of LUVs (large unilamellar vesicles) {#Sec7}
------------------------------------------------

LUVs were prepared from POPC/POPS in a 7:3 molar ratio. Stock solutions of POPC and POPS in chloroform at concentrations of 20--30 m[M]{.smallcaps} were mixed in a 7:3 molar ratio in a glass tube. The solvent was evaporated with dry nitrogen gas yielding a lipid film that was subsequently kept in a vacuum desiccator for 20 min. Lipid films were hydrated in 10 m[M]{.smallcaps} phosphate buffer (pH 7.4) for at least 30 min, at a lipid concentration of 10 m[M]{.smallcaps}. The lipid suspensions were subjected to ten freeze--thaw cycles, at temperatures of approximately −80 and 40°C, and subsequently extruded ten times through 0.2 μm pore-size filters (Anotop 10; Whatman, Maidstone, UK).

CD spectroscopy {#Sec8}
---------------

CD spectra were acquired on a Jasco 810 spectropolarimeter (Jasco, Easton, MD, USA) over the wavelength range 190--270 nm at room temperature. Measurements were carried out in cells of 0.1 mm path length at room temperature in POPC/POPS (7:3) LUVs. Measurements were taken every 0.2 nm at a scan rate of 20 nm/min. Each spectrum reported is the average of five scans after subtraction of the baseline spectrum of the vesicles without peptide. Peptide concentrations were 50 μ[M]{.smallcaps} in the presence of lipids (peptide-to-lipid ratio 1:20). In order to estimate the peptide secondary structure content, analysis of relevant CD spectra was carried out using CDPro2 software (Sreerama and Woody [@CR30]). The analysis was performed using the self-consistent method Contin-LL and the basis 10 that contains 56 reference proteins.

Sample preparation for NMR experiments {#Sec9}
--------------------------------------

Mixtures of POPC and POPS (ratio 7:3) were co-dissolved in chloroform and evaporated under vacuum. The residual lipid film was hydrated in Tris--HCl, 100 m[M]{.smallcaps} NaCl buffer (pH 7.4). The solution was subjected to ten freeze--thaw cycles, at temperatures of approximately −80 and 40°C, to homogenize the size of the MLV. For the samples containing the peptide, the lipid solution was added to the film of peptide at the beginning of the MLV preparation. A total lipid-to-peptide ratio of 20:1 was used.

NMR experiments {#Sec10}
---------------

NMR experiments were carried out on a Bruker Advance 500 MHz NMR spectrometer. ^2^H NMR experiments on deuterated lipids were performed at 76.78 MHz using a quadrupolar echo sequence. Typical acquisition conditions were: 2.5 μs 90° pulse, an echo delay of 50 μs, a recycling delay of 1.5 s, 500 kHz spectral width, 4096 data points, 36000 scans. A line broadening of 100--200 Hz was applied prior to Fourier transformation. The temperature was regulated at 25 ± 1°C. To gather information about effects of the peptides on local chain order, powder spectra were processed using the "de-Pake-ing" procedure, implemented by Bloom et al. ([@CR5]). The order parameters,*S*~CD~, were calculated by use of NMRFriend software (Buchoux et al. [@CR7]).

Results and discussion {#Sec11}
======================

To evaluate the role of the disulfide bond in hIAPP~1--19~ on its membrane interactions, we synthesized two hIAPP~1--19~ peptides: an oxidized form and a protected form with a methyl group on each cysteine residue to avoid the formation of the disulfide bond during the experiments. The amino acid sequences of the peptides are shown in Fig. [1](#Fig1){ref-type="fig"}.

The oxidized peptide has a slightly higher tendency to insert than the protected peptide {#Sec12}
----------------------------------------------------------------------------------------

To study the insertion of the peptides in lipid membranes, we performed monolayer experiments. Injection of a solution of either oxidized or protected hIAPP~1--19~ into the aqueous sub-phase below a POPC/POPS (7:3) monolayer resulted in a fast increase in the surface pressure after addition of each peptide. After 20 min, at an initial surface pressure of 24 mN/m, the increase in surface pressure induced by insertion of the oxidized hIAPP~1--19~ was 9.0 ± 0.5 mN/m, compared with an increase of 7.5 ± 0.5 mN/m for the protected hIAPP~1--19~ (Fig. [2](#Fig2){ref-type="fig"}a), indicating efficient insertion for both peptides.Fig. 2**a** Surface pressure profile after injecting a sample of hIAPP~1--19~ oxidized (*solid line*) and protected (*dashed line*) into a monolayer of POPC/POPS (7:3). The peptides were injected into the stirred sub-phase at *t* = 0 min. The final peptide concentration was 1 μ[M]{.smallcaps}. **b** Surface pressure increase induced by the interaction of freshly dissolved hIAPP~1--19~ oxidized (*diamonds*, *solid line*) and protected (*triangles*, *dashed line*) with POPC/POPS (7:3) monolayers as a function of the initial surface pressure. The final peptide concentration was 1 μ[M]{.smallcaps}. The *straight lines* were obtained by linear regression. Experimental error is estimated at ±0.5 mN/m

Next, we determined the maximal initial surface pressure at which the peptides were still able to insert, i.e. cause a further increase in surface pressure, by analysing the surface pressure increase as a function of initial surface pressure. The data from Fig. [2](#Fig2){ref-type="fig"}b indicate that the extrapolated "limiting surface pressure" is high for all peptides and it seems to be slightly higher for the oxidized peptide (47.2 ± 0.7 mN/m) than for the protected peptide (44.7 ± 0.8 mN/m). In both cases, the limiting surface pressure is significantly higher than the surface pressures that correspond to the packing density in lipids in biological membranes, between 31 and 35 mN/m (Demel et al. [@CR9]), indicating that in vivo also hIAPP~1--19~ can insert efficiently into membranes. The limiting surface pressure of hIAPP is of the same order, or even higher, than that of peptides with a known membrane activity, for example neuropeptides and antimicrobial peptides (Calvez et al. [@CR8]). Thus, our results suggest that both peptides insert very efficiently into membranes, but that the oxidized peptide has a slightly higher capacity to insert than the protected peptide.

The oxidized peptide induces slightly more acyl chain disorder than the protected peptide {#Sec13}
-----------------------------------------------------------------------------------------

Next we investigated the effect of membrane insertion of these peptides on lipid chain order by ^2^H NMR. The peptides were incorporated into bilayers of perdeuterated POPC/POPS at a 1:20 peptide-to-lipid molar ratio. ^31^P NMR measurements confirmed that the lipids in these systems are in a bilayer organization (data not shown). Figure [3](#Fig3){ref-type="fig"}a presents the ^2^H NMR spectra of POPC-^2^H~31~/POPS bilayer dispersions, with and without the peptides at 25°C. In the case of POPC-^2^H~31~/POPS, we observe the typical behavior of this system, characteristic of a lamellar fluid phase (Salnikov et al. [@CR28]). The spectra exhibit many resolved splittings. The smallest splitting, corresponding to the methyl groups at the end of the acyl chains, is about 5.0 kHz and the largest, corresponding to the CD~2~ groups closest to the glycerol backbone, is approximately 25.9 kHz. In the presence of the peptides, no characteristic changes in spectrum shape occur. Thus, addition of the oxidized peptide or the protected peptide does not induce a global perturbation of the dynamics of the membrane matrix. However, the width of the spectra seems slightly reduced, with the largest splitting now being 24.9 kHz for the protected peptide and 24.1 kHz for the oxidized peptide. Figure [3](#Fig3){ref-type="fig"}b shows the profile of the order parameter (*S*~CD~) for each carbon position in the lipid chain in the presence and in the absence of peptide. The POPC-^2^H~31~ chain order is lower when either peptide is present in the system. This is particularly true for the "plateau" positions (carbons 2 to 6). Toward the chain end (positions 15 and 16) the effect is less marked or absent. In addition, our results show that the POPC-^2^H~31~ chain order is lower with the oxidized peptide than with the protected one. The ^2^H NMR spectra of POPC/POPS-^2^H~31~ bilayer dispersions were also recorded. The same effect as for the POPC-^2^H~31~/POPS bilayer was observed. The membrane-disorder induced by hIAPP is of the same order as that of peptides with a known membrane activity, for example antimicrobial peptides (Salnikov et al. [@CR28]; Balla et al. [@CR4]). In addition, it was recently shown that Aβ42, the peptide that forms amyloid fibrils in Alzheimer's disease, also induced membrane disorder in POPC/POPS bilayers (Gehman et al. [@CR14]; Lau et al. [@CR22]). This result can be correlated with that of the monolayer study: the oxidized peptide inserts better and induces more disorder into the membrane than the protected peptide, suggesting that the disulfide bond somewhat affects the mode of membrane insertion of hIAPP~1--19~.Fig. 3**a**^2^H NMR spectra for peptides/POPC-*d*~*31*~/POPS dispersions at a 1:20 molar ratio and at 25°C. Spectra are shown without peptide and for samples containing the peptides indicated. **b***S*~CD~ profile without peptide (*squares*), with hIAPP~1--19~ oxidized (*diamonds*) and protected (*triangles*) calculated for de-Paked spectra at 25°C. Carbon position 16 represents the end of the chain. Experimental error is in*symbol size*

The oxidized peptide has slightly less α-helical structure than the protected peptide in the presence of membranes {#Sec14}
------------------------------------------------------------------------------------------------------------------

The small differences in mode of insertion of the oxidized and protected peptide may be because of differences in conformation. We therefore used CD spectroscopy to determine whether the disulfide bridge affects the membrane-bound secondary structure of the peptide in the presence of POPC/POPS membranes. A previous study showed that oxidized hIAPP~1--19~ adopts α-helical structure upon addition of POPG liposomes (Brender et al. [@CR6]). Consistent with this, our CD spectra in POPC/POPS (7:3) of the oxidized peptide display negative ellipticity at 208 and 222 nm, characteristic of α-helical backbone structure (Fig. [4](#Fig4){ref-type="fig"}). A similar spectrum is observed for the protected peptide. However, the minimum of the protected peptide is slightly more intense than the minimum of the oxidized peptide. This suggests that the protected peptide has a slightly larger α-helical content than the oxidized peptide. This is supported by deconvolution of CD traces, where 62% α-helical contribution is obtained for the protected peptide and 58% α-helical for the oxidized peptide (inset of Fig. [4](#Fig4){ref-type="fig"}). This result suggests that in the presence of membranes the disulfide bond only slightly affects the secondary structure of hIAPP~1--19~.Fig. 4CD spectra of 50 μ[M]{.smallcaps} hIAPP~1--19~ oxidized (*bold line*) and protected (*thin line*) in the presence of POPC/POPS 7:3 LUVs (peptide-to-lipid ratio 1:20). The*inset* shows the deconvolution of CD spectra of the peptides

The disulfide bond does not influence the effect of hIAPP~1--19~ on membrane barrier properties or its inability to form amyloid fibers {#Sec15}
---------------------------------------------------------------------------------------------------------------------------------------

We wanted to know if the disulfide has an effect on membrane damage and fibril formation. Membrane damage was assayed quantitatively by analyzing the extent of leakage of a fluorescent dye (calcein) from LUVs. The results demonstrate that neither peptide is able to induce significant membrane damage (leakage \<5%, data not shown), despite their ability to efficiently insert into a lipid monolayer and to induce slight bilayer disorder. Also, under these conditions, i.e. in the presence of POPC/POPS LUVs, neither peptide forms fibrils as determined by transmission electron microscopy and thioflavin T fluorescence, even after 15 days of incubation (data not shown). These findings are in agreement with our previous work, which indicated that fibril growth is a requirement for amyloid-induced membrane damage (Engel et al. [@CR13]).

Conclusion {#Sec16}
==========

Our results suggest that the presence of the disulfide bond has only small effects on membrane interaction of hIAPP. Its removal in hIAPP~1--19~ results in a slight decrease in membrane insertion, a decrease in the effect of the peptide on membrane disorder, and a small increase in α-helical structure. The inability of hIAPP~1--19~ to induce membrane damage and to form fibrils in the presence of membranes is not changed upon removing the disulfide bond.

Based on the results presented here, and on our previous results (Engel et al. [@CR12]), we conclude that the N-terminal residues of IAPP are important for membrane insertion, but that the disulfide linked residues 2--7 seem much less responsible than the other residues (8--19) for this interaction. This notion is in agreement with two recent studies, which indicate that residues 9 to 22 of hIAPP form a helix that binds to phospholipid bilayers (Apostolidou et al. [@CR3]; Nanga et al. [@CR23]) whereas residues 1 to 8, containing the disulfide, do not interact directly with the membrane. Thus, the fact that the cysteines are evolutionarily conserved is most likely related exclusively to the biological activity of IAPP as a hormone, where these cysteines may be involved in interactions with other cellular components than lipids, e.g. with an IAPP receptor.
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